Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea.

Sang Hee YounYeon-Joo KimSang-Soo SeoSokbom KangMyong Cheol LimHa Kyun ChangSang-Yoon ParkJoo-Young Kim

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)

Bevacizumab for stage IVB cervical cancer is associated with higher complete response rates. However, patients treated with bevacizumab experienced more bowel toxicities. Bevacizumab did not improve progression-free survival among patients with node-only metastasis.

Keyphrases

metastatic colorectal cancer
free survival
newly diagnosed
rectal cancer
lymph node
squamous cell carcinoma
radiation therapy